Fore: Stock Predictions Daily Brief

Fore: Stock Predictions Daily Brief · Jan 22, 2026

Listen Later

Fore Stock Predictions Daily Brief - 2026-01-22

Target window: 2026-01-29

Top opportunities:

  • 1. $MU → $339.03 (+6.1%) @ 73% confidence
  • 2. $NVDA → $196.63 (+4.0%) @ 72% confidence
  • 3. $PWR → $458.00 (+4.1%) @ 76% confidence
  • 4. $AMD → $235.01 (+4.8%) @ 70% confidence
  • 5. $NEM → $105.18 (+3.8%) @ 75% confidence
  • 6. $GDX → $88.91 (+3.7%) @ 73% confidence
  • 7. $HWM → $216.44 (+3.6%) @ 75% confidence
  • 8. $ADI → $283.87 (+3.6%) @ 72% confidence
  • 9. $CRM → $264.54 (+4.1%) @ 63% confidence
  • 10. $VRTX → $471.00 (+4.0%) @ 68% confidence

    • Story beats:

    • $MU: Micron's earnings beat, sold-out HBM capacity, AI-driven supercycle, and expansions position it for strong weekly gains amid technical momentum.
    • $NVDA: NVDA's strong AI demand, robust Q3 guidance, China catalysts, and technical uptrend position it for 4-5% upside next week amid solid fundamentals.
    • $PWR: PWR benefits from infrastructure boom, AI-driven demand, record backlog, and strong fundamentals with bullish analyst and technical momentum.
    • $AMD: AMD's rally is propelled by AI demand, analyst upgrades, and strong technicals, positioning it for 6-9% upside next week despite overbought risks.
    • $NEM: NEM poised for gains on surging gold prices, robust fundamentals, and strong technicals amid macro tailwinds.
    • $GDX: GDX benefits from gold's surge on geo-risks, weak dollar, Fed stability, ETF inflows, strong miner fundamentals, and bullish technicals for potential 3-5% weekly gain.
    • $HWM: HWM poised for modest upside from strong fundamentals, aerospace tailwinds, bullish technicals, and analyst upgrades, tempered by pre-earnings caution.
    • $ADI: ADI's Q4 beat, AI-driven guidance, analyst upgrades, and bullish technicals position it for near-term upside in a strong semiconductor sector.
    • $CRM: CRM's oversold technicals, strong Q3 beat with AI growth, insider buying, and analyst support point to 3-4% upside rebound potential near-term.
    • $VRTX: Vertex Pharmaceuticals is poised for gains from key data readouts, strong financials, and biotech tailwinds, with analysts targeting 9-16% upside.

      • Dashboards + charts: https://fore.markets/aggregated-forecast-report-v2?run_id=2026-01-22

      Video + captions also on fore.markets.

      ⚠️ Not financial advice. Markets involve risk. Terms: fore.markets/tos.html | Privacy: fore.markets/privacy.html.

      ...more
      View all episodesView all episodes
      Download on the App Store
      Fore: Stock Predictions Daily BriefBy foremarkets